Boston Scientific stock popped Wednesday after the medtech giant agreed to full acquire Bolt Medical for up to $900 million.

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/97.DU2JpMck.js ...

Boston Scientific inks a new agreement to acquire Bolt Medical, developer of Bolt IVL, for approximately $443 million.

JPMorgan keeps an Overweight rating on Boston Scientific (BSX) with a $110 price target after the company announced an agreement to acquire the ...

Patrick Wood, an analyst from Morgan Stanley, maintained the Buy rating on Boston Scientific (BSX – Research Report). The associated price ...

The agreement strengthens Boston Scientific's Position in Minimally Invasive Treatment for Coronary Artery Disease ...

The biomedical and biotech engineering firm will acquire another development company specializing in cardiovascular disease ...

Ten companies–predominantly gold miners–led Wednesday’s rally on Wall Street, despite the latter’s main indices closing mixed ...

In early validation of widespread predictions of a robust year for M&A activity, Boston Scientific Corp. signed a definitive agreement to acquire the 74% of Bolt Medical Inc. it doesn’t already own ...

Meta Platforms (META) said it would let some users browse eBay listings on [Facebook Marketplace](https:// ...

Johnson & Johnson stock skidded Wednesday after the company temporarily paused sales of its pulsed field ablation system.

The S&P 500 Index Wednesday closed up +0.16%, the Dow Jones Industrials Index closed up +0.25%, and the Nasdaq 100 Index closed up +0.04%. March E-mini S&P futures are up +0.13%, ...